These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 22833668)

  • 1. Identification of two-pore channel 2 as a novel regulator of osteoclastogenesis.
    Notomi T; Ezura Y; Noda M
    J Biol Chem; 2012 Oct; 287(42):35057-35064. PubMed ID: 22833668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The paired-box homeodomain transcription factor Pax6 binds to the upstream region of the TRAP gene promoter and suppresses receptor activator of NF-κB ligand (RANKL)-induced osteoclast differentiation.
    Kogawa M; Hisatake K; Atkins GJ; Findlay DM; Enoki Y; Sato T; Gray PC; Kanesaki-Yatsuka Y; Anderson PH; Wada S; Kato N; Fukuda A; Katayama S; Tsujimoto M; Yoda T; Suda T; Okazaki Y; Matsumoto M
    J Biol Chem; 2013 Oct; 288(43):31299-312. PubMed ID: 23990468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coenzyme q10 regulates osteoclast and osteoblast differentiation.
    Moon HJ; Ko WK; Jung MS; Kim JH; Lee WJ; Park KS; Heo JK; Bang JB; Kwon IK
    J Food Sci; 2013 May; 78(5):H785-891. PubMed ID: 23582186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of matrix metalloproteinase-9 activity by doxycycline ameliorates RANK ligand-induced osteoclast differentiation in vitro and in vivo.
    Franco GC; Kajiya M; Nakanishi T; Ohta K; Rosalen PL; Groppo FC; Ernst CW; Boyesen JL; Bartlett JD; Stashenko P; Taubman MA; Kawai T
    Exp Cell Res; 2011 Jun; 317(10):1454-64. PubMed ID: 21420951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Orai1-mediated calcium entry plays a critical role in osteoclast differentiation and function by regulating activation of the transcription factor NFATc1.
    Hwang SY; Putney JW
    FASEB J; 2012 Apr; 26(4):1484-92. PubMed ID: 22198385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Agelasine D suppresses RANKL-induced osteoclastogenesis via down-regulation of c-Fos, NFATc1 and NF-κB.
    Kang MR; Jo SA; Yoon YD; Park KH; Oh SJ; Yun J; Lee CW; Nam KH; Kim Y; Han SB; Yu J; Rho J; Kang JS
    Mar Drugs; 2014 Nov; 12(11):5643-56. PubMed ID: 25421321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estrogen inhibits RANKL-induced osteoclastic differentiation by increasing the expression of TRPV5 channel.
    Chen F; Ouyang Y; Ye T; Ni B; Chen A
    J Cell Biochem; 2014 Apr; 115(4):651-8. PubMed ID: 24150765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Knockdown of TRPV4 suppresses osteoclast differentiation and osteoporosis by inhibiting autophagy through Ca
    Cao B; Dai X; Wang W
    J Cell Physiol; 2019 May; 234(5):6831-6841. PubMed ID: 30387123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predicting and validating the pathway of Wnt3a-driven suppression of osteoclastogenesis.
    Hamamura K; Chen A; Nishimura A; Tanjung N; Sudo A; Yokota H
    Cell Signal; 2014 Nov; 26(11):2358-69. PubMed ID: 25038457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Saurolactam inhibits osteoclast differentiation and stimulates apoptosis of mature osteoclasts.
    Kim MH; Ryu SY; Choi JS; Min YK; Kim SH
    J Cell Physiol; 2009 Dec; 221(3):618-28. PubMed ID: 19653230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SLAT negatively regulates RANKL-induced osteoclast differentiation.
    Youn BU; Kim K; Kim JH; Lee J; Moon JB; Kim I; Park YW; Kim N
    Mol Cells; 2013 Sep; 36(3):252-7. PubMed ID: 23996528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Blimp1-Bcl6 axis is critical to regulate osteoclast differentiation and bone homeostasis.
    Miyauchi Y; Ninomiya K; Miyamoto H; Sakamoto A; Iwasaki R; Hoshi H; Miyamoto K; Hao W; Yoshida S; Morioka H; Chiba K; Kato S; Tokuhisa T; Saitou M; Toyama Y; Suda T; Miyamoto T
    J Exp Med; 2010 Apr; 207(4):751-62. PubMed ID: 20368579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Receptor activator of nuclear factor-kappaB ligand-induced nuclear factor of activated T cells (C1) autoregulates its own expression in osteoclasts and mediates the up-regulation of tartrate-resistant acid phosphatase.
    Fretz JA; Shevde NK; Singh S; Darnay BG; Pike JW
    Mol Endocrinol; 2008 Mar; 22(3):737-50. PubMed ID: 18063694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Knockout of TRPV6 causes osteopenia in mice by increasing osteoclastic differentiation and activity.
    Chen F; Ni B; Yang YO; Ye T; Chen A
    Cell Physiol Biochem; 2014; 33(3):796-809. PubMed ID: 24686448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SH3BP2 is an activator of NFAT activity and osteoclastogenesis.
    Lietman SA; Yin L; Levine MA
    Biochem Biophys Res Commun; 2008 Jul; 371(4):644-8. PubMed ID: 18440306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The JNK-dependent CaMK pathway restrains the reversion of committed cells during osteoclast differentiation.
    Chang EJ; Ha J; Huang H; Kim HJ; Woo JH; Lee Y; Lee ZH; Kim JH; Kim HH
    J Cell Sci; 2008 Aug; 121(Pt 15):2555-64. PubMed ID: 18650497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased SH3BP2 inhibits osteoclast differentiation and function.
    Kawamoto T; Fan C; Gaivin RJ; Levine MA; Lietman SA
    J Orthop Res; 2011 Oct; 29(10):1521-7. PubMed ID: 21448930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trapidil, a platelet-derived growth factor antagonist, inhibits osteoclastogenesis by down-regulating NFATc1 and suppresses bone loss in mice.
    Kim SD; Kim HN; Lee JH; Jin WJ; Hwang SJ; Kim HH; Ha H; Lee ZH
    Biochem Pharmacol; 2013 Sep; 86(6):782-90. PubMed ID: 23928189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The fungal metabolite (+)-terrein abrogates osteoclast differentiation via suppression of the RANKL signaling pathway through NFATc1.
    Nakagawa S; Omori K; Nakayama M; Mandai H; Yamamoto S; Kobayashi H; Sako H; Sakaida K; Yoshimura H; Ishii S; Ibaragi S; Hirai K; Yamashiro K; Yamamoto T; Suga S; Takashiba S
    Int Immunopharmacol; 2020 Jun; 83():106429. PubMed ID: 32222639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MCP-1-induced human osteoclast-like cells are tartrate-resistant acid phosphatase, NFATc1, and calcitonin receptor-positive but require receptor activator of NFkappaB ligand for bone resorption.
    Kim MS; Day CJ; Selinger CI; Magno CL; Stephens SR; Morrison NA
    J Biol Chem; 2006 Jan; 281(2):1274-85. PubMed ID: 16280328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.